JULUCA Trademark

Trademark Overview


On Wednesday, March 9, 2016, a trademark application was filed for JULUCA with the United States Patent and Trademark Office. The USPTO has given the JULUCA trademark a serial number of 86934462. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, February 7, 2023. This trademark is owned by Glaxo Group Limited. The JULUCA trademark is filed in the Pharmaceutical Products category with the following description:

[ Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; ] Pharmaceutical preparations and substances for the treatment of viral [ metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric ] and immune system related diseases and disorders; [ Vaccines; ] Pharmaceutical preparations and substances for the treatment of infectious diseases [ blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders ]
juluca

General Information


Serial Number86934462
Word MarkJULUCA
Filing DateWednesday, March 9, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, February 7, 2023
Registration Number5059366
Registration DateTuesday, October 11, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2016

Trademark Statements


Amendment to a Registration/Renewal CertificateIn the statement, lines 4-5, "Pharmaceutical preparations and substances for the treatment of damaged skin and tissue;" is deleted, And, In the statement, lines 5- 8, "metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric" is deleted, And, In the statement, line 9, "Vaccines;" is deleted, And, In the statement, lines 10-11, "blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders" is deleted.
Goods and Services[ Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; ] Pharmaceutical preparations and substances for the treatment of viral [ metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric ] and immune system related diseases and disorders; [ Vaccines; ] Pharmaceutical preparations and substances for the treatment of infectious diseases [ blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders ]
Translation of Words in MarkThe wording "JULUCA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 14, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVIIV HEALTHCARE UK (NO. 3) LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, August 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 7, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 7, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 7, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, February 7, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, February 7, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 20, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, October 11, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 16, 2018AMENDMENT UNDER SECTION 7 ¿ PROCESSED
Friday, January 12, 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, January 9, 2018POST REGISTRATION ACTION MAILED - SEC. 7
Monday, January 8, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 12, 2017TEAS SECTION 7 REQUEST RECEIVED
Wednesday, September 20, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 11, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, July 26, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 6, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 21, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 21, 2016ASSIGNED TO EXAMINER
Monday, March 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 12, 2016NEW APPLICATION ENTERED